Ticker > Company >

Innova Captab share price

Innova Captab Ltd.

NSE: INNOVACAP BSE: 544067 SECTOR: Pharmaceuticals & Drugs  19.88 K   59   20

898.00
-1.55 (-0.17%)
BSE: 24 Jul 04:01 PM

Price Summary

Today's High

₹ 917.4

Today's Low

₹ 895.6

52 Week High

₹ 1259

52 Week Low

₹ 568.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

5138.8 Cr.

Enterprise Value

5398.03 Cr.

No. of Shares

5.72 Cr.

P/E

57.44

P/B

6.32

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  142.06

CASH

67.89 Cr.

DEBT

327.13 Cr.

Promoter Holding

50.9 %

EPS (TTM)

₹  15.63

Sales Growth

10.77%

ROE

11.64 %

ROCE

11.6%

Profit Growth

31.26 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.77%
3 Year6.85%
5 Year20.74%

Profit Growth

1 Year31.26%
3 Year10.67%
5 Year26.28%

ROE%

1 Year11.64%
3 Year16.47%
5 Year22.73%

ROCE %

1 Year11.6%
3 Year15.97%
5 Year21.79%

Debt/Equity

0.4024

Price to Cash Flow

259.52

Interest Cover Ratio

56.3003

CFO/PAT (5 Yr. Avg.)

0.856886415226951

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 50.90 0.00
Mar 2025 50.90 0.00
Dec 2024 50.90 0.00
Sep 2024 50.90 0.00
Jun 2024 50.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy Interest coverage ratio of 56.3003.
  • The company has an efficient Cash Conversion Cycle of 22.1905 days.
  • The company has a high promoter holding of 50.9%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.58540738896989.

 Limitations

  • The company has shown a poor revenue growth of 6.84568722028012% for the Past 3 years.
  • The company is trading at a high PE of 57.44.
  • The company is trading at a high EV/EBITDA of 38.8141.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 198.1 226.83 240.18 248.53 242.52
Total Expenditure 174.71 198.39 207 216.03 214.34
Operating Profit 23.39 28.45 33.18 32.49 28.18
Other Income 6.01 4.64 4.28 3.49 4.36
Interest 0.12 0.09 0.08 0.13 1.87
Depreciation 2.93 3.06 3.07 3.08 7.81
Exceptional Items 0 0 0 0 0
Profit Before Tax 26.35 29.95 34.32 32.77 22.86
Tax 6.63 7.61 8.71 8.37 5.73
Profit After Tax 19.72 22.34 25.61 24.4 17.13
Adjusted EPS (Rs) 3.45 3.9 4.47 4.26 2.99

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 410.66 785.46 858.67 864.93 958.06
Total Expenditure 356.18 686.95 760.14 756.96 835.76
Operating Profit 54.49 98.51 98.53 107.97 122.3
Other Income 1.37 2.86 8.73 10.72 16.78
Interest 3.93 5.33 18.3 13.59 2.17
Depreciation 5.59 7.4 10.66 11.4 17.02
Exceptional Items 0 0 0 0 0
Profit Before Tax 46.34 88.63 78.31 93.7 119.89
Tax 11.84 22.46 20.76 25.54 30.42
Net Profit 34.42 66.01 57.55 68.16 89.47
Adjusted EPS (Rs.) 7.19 13.79 11.99 11.91 15.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 12 12 48 57.23 57.23
Total Reserves 132.82 198.83 220.32 666.49 755.74
Borrowings 6 67.35 134.18 208.2 243.55
Other N/C liabilities 3.64 16.74 57.31 9.75 18.47
Current liabilities 215.15 261.56 259.32 237.97 308.83
Total Liabilities 369.62 556.49 719.13 1179.64 1383.81
Assets
Net Block 79.14 161.21 161.37 163.56 637.47
Capital WIP 7.26 0.03 21.54 338.98 21.02
Intangible WIP 0 0 0 0 0
Investments 0 60 60 60 60
Loans & Advances 12.75 21.69 97.58 154.9 111.78
Other N/C Assets 0 0.28 0.26 0.2 5.77
Current Assets 270.46 313.28 378.38 462.01 547.78
Total Assets 369.62 556.49 719.13 1179.64 1383.81
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 46.34 88.63 78.31 93.7 119.89
Adjustment 9.59 12.41 23.58 22.31 13.3
Changes in Assets & Liabilities -1.14 -21.87 -43.7 19.65 -93.99
Tax Paid -13.23 -20.84 -18.91 -23.99 -19.4
Operating Cash Flow 41.56 58.34 39.28 111.67 19.8
Investing Cash Flow -19.67 -188.33 -87.53 -471.55 -99.75
Financing Cash Flow -19.34 125.3 51.29 368.13 83.86
Net Cash Flow 2.56 -4.69 3.03 8.25 3.92

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 50.90 50.90 50.90 50.90 50.90
chhavi lohariwala 0.01 0.01 0.01 0.01 0.01
manoj lohariwala 29.07 29.07 29.07 29.07 29.07
vandana lohariwala 0.01 0.01 0.01 0.01 0.01
vinay kumar lohariwala 21.81 21.81 21.81 21.81 21.81
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 49.10 49.10 49.10 49.10 49.10
360 one special opportuni... - - - - 1.85
360 one special opportuni... 1.77 1.77 1.77 1.77 1.82
archit aggarwal - - - - 8.74
canara robeco mutual fund... - - - - 3.61
clarus capital i 1.31 1.83 1.83 1.88 1.91
gian parkash aggarwal 21.65 21.65 21.65 21.65 10.80
invesco india manufacturi... - 2.61 2.73 - 2.77
kotak mahindra trustee co... - - - - 3.67
sbi life insurance co. lt... 1.82 1.89 1.67 1.82 1.62
veena devi - - - - 1.75
360 one special opportuni... 1.70 1.70 1.70 1.70 -
canara robeco mutual fund... - - - 3.53 -
invesco india midcap fund... 2.47 - - 2.75 -
kotak mahindra trustee co... 3.92 3.86 3.73 3.60 -
canara robeco mutual fund... - 3.66 3.55 - -
canara robeco mutual fund... 3.69 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q1FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY24
Presentation Q1FY25

Innova Captab Stock Price Analysis and Quick Research Report. Is Innova Captab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Innova Captab and its performance over the period of time. Innova Captab stock price today is Rs 899.05.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Innova Captab cash from the operating activity was Rs 19.801 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Innova Captab has a Debt to Equity ratio of 0.4024 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Innova Captab , the EPS growth was 31.2624 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Innova Captab has OPM of 12.7652623371581 % which is a bad sign for profitability.
     
  • ROE: Innova Captab have a average ROE of 11.6446 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Innova Captab is Rs 899.05. One can use valuation calculators of ticker to know if Innova Captab share price is undervalued or overvalued.
Last Updated on:
Brief about Innova Captab
X